» Articles » PMID: 37940569

Clinical Significance of Stiffness During Endoscopic Surgery for Intracerebral Hemorrhage: A Retrospective Study

Overview
Specialties Neurology
Neurosurgery
Date 2023 Nov 8
PMID 37940569
Authors
Affiliations
Soon will be listed here.
Abstract

Studies regarding hematoma stiffness and removal difficulty are scarce. This study explored the association between hematoma stiffness and surgical results of endoscopic hematoma removal for intracerebral hemorrhage. It also aimed to clarify factors associated with hematoma stiffness. We classified intracerebral hematoma as either soft or firm stiffness by retrospectively evaluating operative videos by two neurosurgeons. The interobserver reliability of the classification was assessed by calculating the κ values. We investigated the relationship between hematoma stiffness and surgical results. Favorable hematoma removal (FHR) was defined as a residual hematoma volume of ≤15 mL or removal rate of ≥70%. Furthermore, we compared the background characteristics, imaging findings, and laboratory data between the two groups. Forty patients were included in this study. The mean baseline hematoma volume was 69.9 mL (range, 41.3-97.6 mL). FHR was accomplished in 35 cases (87.5%). Thirty-four patients (85%) were in the soft hematoma group (group S). Six patients (15%) were in the firm hematoma group (group F). Classification of hematoma stiffness demonstrated an excellent degree of interobserver agreement (κ score = 0.91). Patients in group S had a high FHR rate (p = 0.018) and short endoscopic procedure times (p = 0.00034). The island sign was present in group S (p = 0.030). Patients in group F had significantly high fibrinogen levels (p = 0.049) and low serum total calcium (p = 0.032), hemoglobin (p = 0.041), and hematocrit (p = 0.011) levels. Hematoma stiffness during endoscopic surgery for intracerebral hemorrhage correlates with surgical results, including the endoscopic procedure time and accomplishing rate of FHR.

Citing Articles

Long-term efficacy and safety of endoscopic surgery versus small bone window craniotomy for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis and trial sequential analysis.

Guo C, Bai Y, Zhang X, Zhang P, Han S, Fan D BMC Neurol. 2025; 25(1):55.

PMID: 39923002 PMC: 11806684. DOI: 10.1186/s12883-025-04023-9.


The Usefulness of the 3.1-mm-diameter 4K Rigid Endoscope for Intracerebral Hematoma Evacuation.

Okubata H, Taniguchi M, Irizato N, Nakata H, Takenaka T, Fukuya S Neurol Med Chir (Tokyo). 2024; 64(7):283-288.

PMID: 38839298 PMC: 11304443. DOI: 10.2176/jns-nmc.2023-0147.

References
1.
Wang L, Zhang L, Mao Y, Li Y, Wu G, Li Q . Regular-Shaped Hematomas Predict a Favorable Outcome in Patients with Hypertensive Intracerebral Hemorrhage Following Stereotactic Minimally Invasive Surgery. Neurocrit Care. 2020; 34(1):259-270. DOI: 10.1007/s12028-020-00996-2. View

2.
Blacquiere D, Demchuk A, Al-Hazzaa M, Deshpande A, Petrcich W, Aviv R . Intracerebral Hematoma Morphologic Appearance on Noncontrast Computed Tomography Predicts Significant Hematoma Expansion. Stroke. 2015; 46(11):3111-6. DOI: 10.1161/STROKEAHA.115.010566. View

3.
Keep R, Hua Y, Xi G . Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012; 11(8):720-31. PMC: 3884550. DOI: 10.1016/S1474-4422(12)70104-7. View

4.
Little K, Friedman A, Sampson J, Wanibuchi M, Fukushima T . Surgical management of petroclival meningiomas: defining resection goals based on risk of neurological morbidity and tumor recurrence rates in 137 patients. Neurosurgery. 2005; 56(3):546-59. DOI: 10.1227/01.neu.0000153906.12640.62. View

5.
Morotti A, Phuah C, Anderson C, Jessel M, Schwab K, Ayres A . Leukocyte Count and Intracerebral Hemorrhage Expansion. Stroke. 2016; 47(6):1473-8. PMC: 4879062. DOI: 10.1161/STROKEAHA.116.013176. View